Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze

被引:79
作者
Britton, KT [1 ]
Akwa, Y
Spina, MG
Koob, GF
机构
[1] San Diego Vet Adm Med Ctr, Dept Psychiat, San Diego, CA 92161 USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA USA
关键词
neuropeptide Y; corticotropin releasing factor; conflict test; elevated plus maze; anxiety;
D O I
10.1016/S0196-9781(99)00169-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Central administration of neuropeptide Y (NPY) produces anxiolytic-like behavioral effects in rat models of anxiety. Because previous evidence has suggested a relationship between NPY and corticotropin-releasing factor (CRF) in the brain, we have focused on the interaction of these neuropeptide systems in emotional responsiveness to stressful stimuli. Intracerebroventricular administration of CRF produced a marked response suppression in an operant incremental shock conflict paradigm. NPY [(1 mu g, intracerebroventricularly (i.c.v.)] significantly antagonized the response-suppressing effects of CRF (0.75 mu g, i.c.v.) on punished responding in the conflict test at doses that produced little or no behavioral effect when administered alone. Central administration of the CRF antagonist [D-Phe(12), Nle(21,38),C-alpha MeLeu(37)]CRF (D-Phe CRF12-41) alone did not alter punished or unpunished responding in the conflict test. However, pretreatment with the CRF antagonist before a subthreshold dose of NPY (1 mu g, i.c.v.) produced a significant potentiation of the release of punished responding relative to NPY alone and untreated controls. NPY also antagonized the "anxiogenic-like" behavioral effects of CRF in the elevated plus maze. These findings support the hypothesis that NPY and CRF may reciprocally modulate an animal's behavioral response to stressful stimuli. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:37 / 44
页数:8
相关论文
共 54 条
[1]  
AOKI C, 1989, J NEUROSCI, V9, P4333
[2]   CRF ANTAGONIST REVERSES THE ANXIOGENIC RESPONSE TO ETHANOL WITHDRAWAL IN THE RAT [J].
BALDWIN, HA ;
RASSNICK, S ;
RIVIER, J ;
KOOB, GF ;
BRITTON, KT .
PSYCHOPHARMACOLOGY, 1991, 103 (02) :227-232
[3]   CORTICOTROPIN RELEASING-FACTOR (CRF) RECEPTOR ANTAGONIST BLOCKS ACTIVATING AND ANXIOGENIC ACTIONS OF CRF IN THE RAT [J].
BRITTON, KT ;
LEE, G ;
VALE, W ;
RIVIER, J ;
KOOB, GF .
BRAIN RESEARCH, 1986, 369 (1-2) :303-306
[4]  
BRITTON KT, 1988, PSYCHOPHARMACOLOGY, V94, P306
[5]   Anxiolytic activity of NPY receptor agonists in the conflict test [J].
Britton, KT ;
Southerland, S ;
VanUden, E ;
Kirby, D ;
Rivier, J ;
Koob, G .
PSYCHOPHARMACOLOGY, 1997, 132 (01) :6-13
[6]   CHLORDIAZEPOXIDE ATTENUATES RESPONSE SUPPRESSION INDUCED BY CORTICOTROPIN-RELEASING FACTOR IN THE CONFLICT TEST [J].
BRITTON, KT ;
MORGAN, J ;
RIVIER, J ;
VALE, W ;
KOOB, GF .
PSYCHOPHARMACOLOGY, 1985, 86 (1-2) :170-174
[7]  
BROQUA P, 1995, BEHAV PHARMACOL, V6, P215
[8]   STRESS-INDUCED CHANGES OF CIRCULATING NEUROPEPTIDE-Y IN THE RAT - COMPARISON WITH CATECHOLAMINES [J].
CASTAGNE, V ;
CORDER, R ;
GAILLARD, R ;
MORMEDE, P .
REGULATORY PEPTIDES, 1987, 19 (1-2) :55-63
[9]   The hyperphagic effect of 3 alpha-hydroxylated pregnane steroids in male rats [J].
Chen, SW ;
Rodriguez, L ;
Davies, MF ;
Loew, GH .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 53 (04) :777-782
[10]   INCREASE OF PLASMA NEUROPEPTIDE-Y-LIKE IMMUNOREACTIVITY FOLLOWING CHRONIC HYPOXIA IN THE RAT [J].
CHENG, JT ;
CHEN, CF ;
SHUM, AYC ;
WANG, JY ;
CHEN, HI .
NEUROSCIENCE LETTERS, 1992, 140 (02) :211-214